News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vernalis PLC (VNLPY.PK) Signs Drug-Discovery Deal With Genentech (RHHBY)


1/4/2012 8:19:40 AM

U.K. drug developer Vernalis PLC said Wednesday it has signed a drug discovery collaboration with Roche Holding AG's unit Genentech. The company didn't give any financial details of the collaboration which will use Vernalis' drug discovery platform against an undisclosed target. Vernalis, which focuses on diseases of the central nervous system and cancer, has previously said it will focus on partnerships to fund its research activities.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES